Generics - Management, Pharmaceutical

Filter

Current filters:

ManagementPharmaceutical

Popular Filters

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

05-12-2013

Eyal Desheh, acting president and chief executive of the world’s largest generics maker Teva (NYSE:…

CopaxoneGenericsInterviewsManagementPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

Pfizer to separate business into three units: will this lead to spin-outs?

29-07-2013

Moving in a direction already advocated by several analysts, US pharma behemoth Pfizer (NYSE: PFE) today…

GenericsManagementMergers & AcquisitionsPfizerPharmaceutical

US Senate confirms appointment of Marilyn Tavenner as CMS Administrator

16-05-2013

US Health and Human Services (HHS) Secretary Kathleen Sebelius announced that the US Senate has confirmed…

BiotechnologyGenericsHealthcareManagementNorth AmericaPharmaceutical

Pilot project for HIV/AIDS drug management supported by PAHO/WHO and the Global Fund may expand to other countries

07-04-2013

Three Latin American countries - Guatemala, Honduras, and the Dominican Republic - are working to strengthen…

Anti-viralsGenericsHealthcareManagementPharmaceuticalSouth America

New US Federal Trade Commission chairman - Edith Ramirez - to be designated by President

03-03-2013

President Barack Obama intends to designate Edith Ramirez as Chairman of the Federal Trade Commission…

BiotechnologyGenericsManagementNorth AmericaPharmaceuticalRegulation

Stada Arz extends generics deal with Omega Pharma; Omega appointments

03-02-2013

German drugmaker Stada Arzneimittel's (SAZ: GR) Belgian subsidiary, Eurogenerics, and the pharmaceutical…

EuropeGenericsManagementMarkets & MarketingOmega PharmaPharmaceuticalSTADA Arzneimittel

Daiichi Sankyo and Ranbaxy combine business operations in Thailand

16-01-2013

Japanese pharma major Daiichi Sankyo (TYO: 4568) and its 64%-owned affiliate Ranbaxy Laboratories (AB:…

Asia-PacificDaiichi SankyoGenericsManagementMarkets & MarketingPharmaceuticalRanbaxy Laboratories

European Parliament starts clinical trial talks; EGA chief resigns

15-11-2012

The European Parliament is about to start discussions regarding Clinical Trials that are vital to get…

EuropeGenericsManagementPharmaceuticalRegulationResearch

Senior appointments at Teva and Johnson & Johnson

14-09-2012

Israel's Teva Pharmaceutical Industries (NYSE: TEVA) has announced the appointment of Itzhak Krinsky…

GenericsJohnson & JohnsonManagementPharmaceuticalTeva Pharmaceutical Industries

Teva's EPS rockets, helped by higher sales in USA

03-08-2012

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic drugs producer…

CephalonFinancialGenericsManagementPharmaceuticalTeva Pharmaceutical Industries

Exec appointments at Novo Nordisk and Teva

09-05-2012

Danish insulin giant Novo Nordisk (NOV: N) says that former Pfizer executive Robert Clark will be joining…

GenericsManagementNovo NordiskPharmaceuticalTeva Pharmaceutical Industries

Knighthood for GlaxoSmithKline’s Andrew Witty; Teva succession plan

03-01-2012

Andrew Witty, chief executive of UK drug giant GlaxoSmithKline (LSE: GSK) has been awarded a Knighthood…

GenericsGlaxoSmithKlineManagementPharmaceuticalTeva Pharmaceutical Industries

Management changes at Mylan, Transition Thera, Pfizer and ShangPharma

12-12-2011

US generic drug major Mylan (Nasdaq: MYL) has announced the appointment of John Thievon as president…

GenericsManagementMylan LaboratoriesPharmaceuticalShangPharmaTransition Therapeutics

AstraZeneca expands in China, cuts back in USA

08-12-2011

It was a busy couple of days for Anglo-Swedish drug major AstraZeneca (LSE: AZN), with the company yesterday…

Asia-PacificAstraZenecaGenericsGuangdong BeiKang PharmaManagementMergers & AcquisitionsNorth AmericaPharmaceutical

Back to top